Heart failure drug combo study aims to improve fluid control
NCT ID NCT04438213
First seen Nov 01, 2025 · Last updated Jun 03, 2026 · Updated 31 times
Summary
This study tests whether adding ertugliflozin (a diabetes drug) or metolazone to standard diuretics helps control fluid buildup and heart failure symptoms better than placebo. About 60 adults with chronic heart failure who already take daily diuretics will participate. Researchers will measure changes in blood volume and sodium excretion over 7 days and 6 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yale School of Medicine
RECRUITINGNew Haven, Connecticut, 06510, United States
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.